Lixisenatide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Lixisenatide. Educational only — not medical advice.
Labeled uses
SOLIQUA 100/33 is a combination of insulin glargine and lixisenatide and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Source: FDA labeling via NIH DailyMed (set 4bba538b…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.